30645688 23509349 24497358 32440537 32690658 26207886 30673885 30275535 25777751 32897883 26821245 34282144 25259415 24449581 26283380 23557436 32582209 31118934 25252121 29860420 28525378 26717913 24449582 22933628 24215615 30061896 26657791 2523809 - Search Results

Year	Number of Results
2012	1
2013	7
2014	9
2015	8
2016	7
2017	1
2018	6
2019	4
2020	5
2021	2
2022	1
2023	0

1

Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.

Barnes BJ. Barnes BJ. Curr Rheumatol Rep. 2019 Jan 15;21(1):2. doi: 10.1007/s11926-019-0803-3. Curr Rheumatol Rep. 2019. PMID: 30645688 Review.

2

Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells.

Weinstein JS, Delano MJ, Xu Y, Kelly-Scumpia KM, Nacionales DC, Li Y, Lee PY, Scumpia PO, Yang L, Sobel E, Moldawer LL, Reeves WH. Weinstein JS, et al. J Immunol. 2013 Apr 15;190(8):3916-27. doi: 10.4049/jimmunol.1201880. Epub 2013 Mar 18. J Immunol. 2013. PMID: 23509349 Free PMC article.

3

Induced murine models of systemic lupus erythematosus.

Xu Y, Zeumer L, Reeves WH, Morel L. Xu Y, et al. Methods Mol Biol. 2014;1134:103-30. doi: 10.1007/978-1-4939-0326-9_9. Methods Mol Biol. 2014. PMID: 24497358

4

Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization.

Banga J, Srinivasan D, Sun CC, Thompson CD, Milletti F, Huang KS, Hamilton S, Song S, Hoffman AF, Qin YG, Matta B, LaPan M, Guo Q, Lu G, Li D, Qian H, Bolin DR, Liang L, Wartchow C, Qiu J, Downing M, Narula S, Fotouhi N, DeMartino JA, Tan SL, Chen G, Barnes BJ. Banga J, et al. Sci Adv. 2020 May 15;6(20):eaay1057. doi: 10.1126/sciadv.aay1057. eCollection 2020 May. Sci Adv. 2020. PMID: 32440537 Free PMC article.

5

Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions.

Yan J, Hedl M, Abraham C. Yan J, et al. J Immunol. 2020 Aug 15;205(4):1024-1038. doi: 10.4049/jimmunol.1900743. Epub 2020 Jul 20. J Immunol. 2020. PMID: 32690658 Free PMC article.

6

Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.

Eames HL, Corbin AL, Udalova IA. Eames HL, et al. Transl Res. 2016 Jan;167(1):167-82. doi: 10.1016/j.trsl.2015.06.018. Epub 2015 Jul 4. Transl Res. 2016. PMID: 26207886 Review.

7

The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.

Fike AJ, Elcheva I, Rahman ZSM. Fike AJ, et al. Curr Rheumatol Rep. 2019 Jan 23;21(1):3. doi: 10.1007/s11926-019-0801-5. Curr Rheumatol Rep. 2019. PMID: 30673885 Review.

8

E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Chong Z, Bao C, He J, Chen T, Zhong L, Li G, Li H, Fang L, Song Y, Fu G, Yang X, Lai L, Liu Y, Wang Q. Chong Z, et al. Cell Mol Immunol. 2018 Dec;15(12):1057-1070. doi: 10.1038/s41423-018-0167-z. Epub 2018 Oct 1. Cell Mol Immunol. 2018. PMID: 30275535 Free PMC article.

9

Animal models of lupus and lupus nephritis.

Du Y, Sanam S, Kate K, Mohan C. Du Y, et al. Curr Pharm Des. 2015;21(18):2320-49. doi: 10.2174/1381612821666150316115727. Curr Pharm Des. 2015. PMID: 25777751 Review.

10

Inhibition of IRF5 hyperactivation protects from lupus onset and severity.

Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K, Sun S, He M, Thompson CD, Li D, Shih T, Tan N, Al-Abed Y, Capitle E, Aranow C, Mackay M, Clapp WL, Barnes BJ. Song S, et al. J Clin Invest. 2020 Dec 1;130(12):6700-6717. doi: 10.1172/JCI120288. J Clin Invest. 2020. PMID: 32897883 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results